Skip to main content
LIR Life Sciences Corp. (CSE:SKNY)
Canada flag Canada · Delayed Price · Currency is CAD
0.980
+0.050 (5.38%)
Mar 6, 2026, 2:31 PM EST

LIR Life Sciences Balance Sheet

Millions CAD. Fiscal year is May - Apr.
Fiscal Year
 TTM FY 2025 FY 2024
Period Ending
 Oct '25 Apr '25 Apr '24
Cash & Equivalents
1.070.120.2
Cash & Short-Term Investments
1.070.120.2
Cash Growth
--38.01%-
Other Receivables
0.02-0.01
Receivables
0.02-0.01
Total Current Assets
1.10.120.2
Total Assets
1.20.120.2
Accounts Payable
0.510.20.04
Short-Term Debt
--0.19
Total Current Liabilities
0.510.20.23
Total Liabilities
0.510.20.23
Common Stock
1.480.30
Retained Earnings
-0.79-0.45-0.03
Comprehensive Income & Other
-0.07-
Shareholders' Equity
0.69-0.08-0.03
Total Liabilities & Equity
1.20.120.2
Total Debt
--0.19
Net Cash (Debt)
1.070.120
Net Cash Growth
-147336.58%-
Net Cash Per Share
0.070.020.01
Filing Date Shares Outstanding
27.8718.950.01
Total Common Shares Outstanding
22.31190.01
Working Capital
0.59-0.08-0.03
Book Value Per Share
0.03-0.00-2.11
Tangible Book Value
0.59-0.08-0.03
Tangible Book Value Per Share
0.03-0.00-2.11
Source: S&P Capital IQ. Standard template. Financial Sources.